YTHDF1 and hepatocellular carcinoma: Additionally, the association of YTHDF1 overexpression with poor prognosis in hepatocellular carcinoma suggests its potential as a prognostic biomarker.32, 33, 34 However, further studies are required to understand their regulation in T cell-mediated hepatitis.